3,5-dimethyl 1-benzyl-4-oxo-2,6-bis(pyridin-2-yl)piperidine-3,5-dicarboxylate, 250mg

(11bS)-N-(Diphenylmethyl)-N-(i-propyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 97%, 100mg

13-Oxa-6,7-dithia-2,11-diazapentadecanoic acid, 3,10-dicarboxy-14,14-dimethyl-12-oxo-, 1-(1,1-dimethylethyl) ester, [R-(R*,R*)]- 9CI, ?97.0%, 1g

(4-(Benzyloxy)-3,5-difluorophenyl)boronic acid, 95.0%, 5g

3-Methoxypropyl acrylate, 98%, 5g

N,N'-Dibenzylethylenediamine Diacetate>97.0%(T)25g

3-Amino-n-(2-methylpropyl)propanamide hydrochloride, 95+%, 500mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95.0%, 1g

4-methyl-5-pyridin-2-yl-4H-1,2,4-triazole-3-thiol, 1g

Potassium (cyclopentylmethyl)trifluoroborate, 97.0%, 5g

TRANS-CYCLOHEXANECARBOXYLIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, METHYL ESTER, 95.0%, 5g

2-(Dimethoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

5-(2,3-difluorophenyl)-5-oxovaleric acid, 97.0%, 2g